Impact of angiotensin-converting enzyme inhibition on renal cortical nitrotyrosine content during increased extracellular glucose concentration

Clinical Biochemistry

Volumn 39, Issue 6, 2006, Pages 633-639

  Ishii, Naohito ^a   Ikenaga, Hideki ^b   Carmines, Pamela K ^c   Takada, Nobukazu ^a   Okazaki, Toshio ^a   Nagai, Tatsuo ^a   Maeda, Tadakazu ^a   Aoki, Yoshikazu ^d   Saruta, Takao ^e   Katagiri, Masato ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Ikenaga Clinic   (Japan)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Kanagawa Health Service Association   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibition; Diabetes mellitus; Nitric oxide; Peroxynitrite; Protein tyrosine nitration; Superoxide anion; Superoxide dismutase

Indexed keywords

3 NITROTYROSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; GLUCOSE; NITRATE; NITRITE; OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HYPERGLYCEMIA; KIDNEY CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE HOMOGENATE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; GLUCOSE; KIDNEY CORTEX; MALE; NITRATES; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; SUPEROXIDES; TYROSINE;

EID: 33745185328     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.02.005     Document Type: Article

References (46)

1. American diabetes association: diabetes nephropathy. Diabetes Care 25 (2002) S85-S89 (Suppl.)
2. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol.: Cell Physiol. 271 (1996) C1424-C1437
3. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1620-1624
4. Schoonmaker G.C., Fallet R.W., and Carmines P.K. Superoxide anion curbs nitric oxide modulation of afferent arteriolar AngII responsiveness in diabetes mellitus. Am. J. Physiol.: Renal. Physiol. 278 (2000) F302-F309
5. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
6. Ikenaga H., Ishii N., Didion S.P., Zhang K., Cornish K.G., Patel K.P., et al. Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure. Am. J. Physiol.: Renal. Physiol. 276 (1999) F79-F87
7. Davis K.L., Martin E., Turko I.V., and Murad F. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 203-236
8. Hanafy K.A., Krumenacker J.S., and Murad F. NO, nitrotyrosine, and cyclic GMP in signal transudation. Med. Sci. Monit. 7 (2001) 801-819
9. Greenacre S.A.B., and Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radical Res. 34 (2001) 541-581
10. Ishii N., Patel K.P., Lane P.H., Taylor T., Bian K., Murad F., et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J. Am. Soc. Nephrol. 12 (2001) 1630-1639
11. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269 (1994) 9889-9897
12. Onozato M.L., Tojo A., Goto A., Fujita T., and Wilcox C.S. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int. 61 (2002) 186-194
13. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem. Res. Toxicol. 9 (1996) 836-844
14. Lewis E.J., Hunsicker L.G., Bain R.P., and Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329 (1993) 1456-1462
15. Hirata Y., Hayakawa H., Kakoki M., Tojo A., Suzuki E., Kimura K., et al. Nitric oxide release from kidneys of hypertensive rats treated with imidapril. Hypertension 27 (1996) 672-678
16. Ruggenenti P., Perna A., and Remuzzi G. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. J. Am. Soc. Nephrol. 12 (2001) 2832-2837
17. The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann. Intern. Med. 134 (2001) 370-379
18. Cooper M.E. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352 (1998) 213-219
19. de Cavanagh E.M., Inserra F., Toblli J., Stella I., Fraga C.G., and Ferder L. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38 (2001) 1130-1136
20. Sugimoto K., Tsuruoka S., and Fujimura A. Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties. Clin. Exp. Pharmacol. Physiol. 28 (2001) 826-830
21. Shultz P.J., and Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90 (1992) 1718-1725
22. Rovin B.H., Wurst E., and Kohan D.E. Production of reactive oxygen species by tubular epithelial cells in culture. Kidney Int. 37 (1990) 1509-1514
23. Bulucu F., Vural A., Aydin A., and Sayal A. Oxidative stress status in adults with nephrotic syndrome. Clin. Nephrol. 53 (2000) 169-173
24. Imam S.Z., and Ali S.F. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation. Brain Res. 855 (2000) 186-191
25. Husdan H., and Rapoport A. Estimation of creatinine by the Jaffe reaction. A comparison of three methods. Clin. Chem. 14 (1968) 222-238
26. Ohishi K., and Carmines P.K. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J. Am. Soc. Nephrol. 5 (1995) 1559-1566
27. Harrison-Bernard L.M., Imig J.D., and Carmines P.K. Renal AT1 receptor protein expression during the early stage of diabetes mellitus. Int. J. Exp. Diabetes Res. 3 (2002) 97-108
28. Aydin A., Orhan H., Sayal A., Ozata M., Sahin G., and Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin. Biochem. 34 (2001) 65-70
29. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
30. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
31. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
32. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 789-790
33. Pou S., Pou W.S., Bredt D.S., Snyder S.H., and Rosen G.M. Generation of superoxide by purified brain nitric oxide synthase. J. Biol. Chem. 267 (1992) 24173-24176
34. Turko I.V., and Murad F. Protein nitration in cardiovascular diseases. Pharmacol. Rev. 54 (2002) 619-634
35. Cudd A., and Fridovich I. Electrostatic interactions in the reaction mechanism of bovine erythrocyte superoxide dismutase. J. Biol. Chem. 257 (1982) 11443-11447
36. Faraci F.M., and Didion S.P. Vascular protection superoxide dismutase isoforms in the vessel wall. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1367-1373
37. Sechi L.A., Ceriello A., Griffin C.A., Catena C., Amstad P., Schambelan M., et al. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40 (1997) 23-29
38. Arai K., Iizuka S., Tada Y., Oikawa K., and Taniguchi N. Increase in the glucosylated form of erythrocyte Cu-Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim. Biophys. Acta 924 (1987) 292-296
39. Abou-Seif M.A., and Youssef A.A. Evaluation of some biochemical changes in diabetic patients. Clin. Chim. Acta 346 (2004) 161-170
40. Nathan C., and Xie Q.W. Nitric oxide synthase: roles, tolls, and controls. Cell 78 (1994) 915-918
41. Porasuphatana S., Tsai P., and Rosen G.M. The generation of free radicals by nitric oxide synthase. Comp. Biochem. Physiol., C Toxicol. Pharmacol. 134 (2003) 281-289
42. Ishii N., Ikenaga H., Carmines P.K., Aoki Y., Ogawa Z., Saruta T., et al. High glucose augments arginase activity and nitric oxide production in the renal cortex. Metabolism 53 (2004) 868-874
43. Kamisaki Y., Wada K., Bian K., Balabanli B., Davis K., Martin E., et al. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 11584-11589
44. Lewis E.J., Hunsicker L.G., Clarke W.R., Berl T., Pohl M.A., Lewis J.B., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345 (2001) 851-860
45. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., et al. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345 (2001) 861-869
46. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., and Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345 (2001) 870-878